George M Milne Jr is Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 29,079 shares of CRL, which is worth approximately $6.23 Million. The most recent transaction as insider was on May 07, 2021, when has been sold 662 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.1K
0% 3M change
0% 12M change
Total Value Held $6.23 Million

GEORGE M MILNE Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 07 2021
BUY
Grant, award, or other acquisition
-
662 Added 2.23%
29,079 Common Stock
Mar 01 2021
SELL
Open market or private sale
$1,023,735 $290.01 p/Share
3,530 Reduced 11.05%
28,417 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$184,584 $52.29 p/Share
3,530 Added 9.95%
31,947 Common Stock

Also insider at

AUPH
Aurinia Pharmaceuticals Inc. Healthcare
AMLX
Amylyx Pharmaceuticals, Inc. Healthcare
GMM

George M Milne Jr

Director
Wilmington, MA

Track Institutional and Insider Activities on CRL

Follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL